The historically low cure rates offered by traditional radiotherapy and proton therapy are being replaced by almost unbelievable treatment outcomes from the combination of modern brachytherapy and IMRT
Mesa, AZ (Vocus) August 24, 2009 -- New innovations in treating prostate cancer have more than doubled the cure rate for high-risk patients. Traditional proton and photon therapies have an approximate 40% success rate for patients with advanced prostate cancer. In sharp contrast, new combined therapies discussed on Doctorfinders.com, have shown cure rates as high as 98% for patients in expert hands.
An estimated 234,000 new cases of prostate cancer will be diagnosed in the United States this year, making it one of the most common cancers affecting American men, second only to skin cancer. More than 27,000 deaths due to prostate cancer are expected to occur this year.
Prostate cancer is most often diagnosed through a blood test measuring the amount of prostate specific antigens (PSA) in the body. However, signs and symptoms of prostate cancer can include: Changes in urinary flow: frequency, urgency, and hesitancy. Also, frequent nighttime urination, painful urination, or blood in urine.
The good news is that the outlook for men diagnosed with prostate cancer is better than ever. When prostate cancer is detected early, while the tumor is still localized, the survival rate is extremely high.
Dr. Jamie Cesaretti, a prostate cancer specialist with the Florida Radiation Oncology Group and contributor to Doctorfinders.com says, "It is an exciting time in prostate cancer radiotherapy treatment. Old concepts of radiotherapy using standard treatments have largely been replaced with new more precise therapies called image-guided brachytherapy (seed-implants) and/or intensity modulation radiation therapy (IMRT)."
The historically low cure rates offered by traditional radiotherapy and proton therapy are being replaced by almost unbelievable treatment outcomes from the combination of modern brachytherapy and IMRT. "A combination of brachytherapy and IMRT can cure between 98% for low-risk patients, 95% for intermediate risk and 85% for high risk patients in expert hands," says Dr. Cesaretti.
The concept behind the combination treatment is simple; the brachytherapy seed implant causes a minimum amount of symptoms while still targeting the cancer. In addition, the IMRT treatment dose is also lowered to also decrease symptoms. In combination, the two high-tech treatments punish the cancer while leaving most men with an excellent quality of life in terms of their ability to have and maintain an erection and live without bowel and bladder symptoms.
Dr. Cesaretti and his partners perform over 500 prostate seed implants per year. He has a special interest in the treatment of prostate cancer with a combination of IMRT and brachytherapy. Dr. Cesaretti's profile can be found at Doctorfinders.com.
DoctorFinders.com is an innovative tool that allows the general public to easily access information about health concerns and find the right doctor for their needs. The site allows for users to identify doctors by geographic area, specialties, procedures, and more.
Read the full story at http://www.prweb.com/releases/Doctors/Prostate_Cancer/prweb2786414.htm.
Copyright©2009 Vocus, Inc.
All rights reserved